Finn K. Hansen
- Molecular Biology top 5%
- Histone Deacetylase Inhibitors Research 71
- Protein Degradation and Inhibitors 34
- Chemical Synthesis and Analysis 17
- Ubiquitin and proteasome pathways 8
- Oncology top 5%
- Peptidase Inhibition and Analysis 34
- Organic Chemistry top 5%
- Click Chemistry and Applications 18
- Synthesis and Biological Evaluation 5
- Physiology top 10%
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment 9
- Co-authors
- Thomas KurzMatthias U. KassackAlexandra HamacherHolger GohlkeNina ReßingAndrea SchölerLinda MarekDavid W. Christianson
- Journals
- Angewandte Chemie International Edition (1 paper)PLoS ONE (1 paper)Chemical Communications (2 papers)
- Partner nations
- GermanyUnited StatesAustralia
In The Last Decade
Finn K. Hansen
93 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 93
- Molecular Biology 1.6k
- Oncology 593
- Organic Chemistry 456
- Physiology 38
- Infectious Diseases 120
Countries citing papers authored by Finn K. Hansen
This map shows the geographic impact of Finn K. Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Finn K. Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Finn K. Hansen more than expected).
Fields of papers citing papers by Finn K. Hansen
This network shows the impact of papers produced by Finn K. Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Finn K. Hansen. The network helps show where Finn K. Hansen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Finn K. Hansen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2026 | 0 | |
| 3 | 2025 | 7 | |
| 4 | 2025 | 8 | |
| 5 | 2025 | 4 | |
| 6 | 2025 | 5 | |
| 7 | 2025 | 0 | |
| 8 | 2025 | 3 | |
| 9 | 2024 | 2 | |
| 10 | 2024 | 1 | |
| 11 | 2024 | 1 | |
| 12 | 2024 | 9 | |
| 13 | 2024 | 2 | |
| 14 | 2024 | 18 | |
| 15 | 2023 | 10 | |
| 16 | 2023 | 15 | |
| 17 | 2022 | 1 | |
| 18 | 2021 | 31 | |
| 19 | 2020 | 9 | |
| 20 | 2018 | 62 |
About Finn K. Hansen
Finn K. Hansen is a scholar working on Oncology, Molecular Biology and Organic Chemistry, having authored 101 papers that have together received 1.9k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (71 papers), Peptidase Inhibition and Analysis (34 papers), Protein Degradation and Inhibitors (34 papers), Click Chemistry and Applications (18 papers), Chemical Synthesis and Analysis (17 papers), HIV/AIDS drug development and treatment (9 papers), Ubiquitin and proteasome pathways (8 papers) and Synthesis and Biological Evaluation (5 papers). The work is most often cited by research in Molecular Biology (1.6k citations), Oncology (593 citations) and Organic Chemistry (456 citations). Finn K. Hansen has collaborated with scholars based in Germany, United States and Australia. Frequent co-authors include Thomas Kurz, Matthias U. Kassack, Alexandra Hamacher, Holger Gohlke, Nina Reßing, Andrea Schöler, Linda Marek, David W. Christianson, Achim Aigner and Thomas Büch. Their work appears in journals such as Angewandte Chemie International Edition, PLoS ONE and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.